CAY10746

Overview

CAY10746 is a selective Rho kinase ( ROCK ) inhibitor. CAY10746 has inhibitory activity for ROCK I , ROCK II with IC 50 values of 0.014 μM and 0.003 μM, respectively. CAY10746 can be used for the research of diabetic retinopathy (DR).

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Glucose Metabolism | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > ROCK

Product Information

• Catalog No.: HY-139170
• CAS No.: 2247240-76-0
• Molecular Formula: C26H23N3O5
• Molecular Weight: 457.48
• Purity: 98.61%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.08 mg/mL (4.55 mM); Clear solution
• Availability: In-stock

Source

Original product source